Jane Street’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-305,000
| Closed | -$25.9M | – | 8508 |
|
|
2020
Q3 | $25.9M | Sell |
305,000
-588,400
| -66% | -$29.8M | 0.02% | 641 |
|
|
2020
Q2 | $31.7M | Buy |
893,400
+830,100
| +1,311% | +$24.3M | 0.02% | 534 |
|
|
2020
Q1 | $853K | Sell |
63,300
-209,500
| -77% | -$3.52M | ﹤0.01% | 2984 |
|
|
2019
Q4 | $5.77M | Buy |
272,800
+244,000
| +847% | +$4.3M | 0.01% | 972 |
|
|
2019
Q3 | $382K | Buy |
+28,800
| New | +$423K | ﹤0.01% | 3875 |
|
|
2019
Q2 | – | Sell |
-16,200
| Closed | -$311K | – | 6046 |
|
|
2019
Q1 | $311K | Sell |
16,200
-7,200
| -31% | -$116K | ﹤0.01% | 4217 |
|
|
2018
Q4 | $334K | Buy |
+23,400
| New | +$465K | ﹤0.01% | 3937 |
|
|
2018
Q3 | – | Sell |
-17,700
| Closed | -$419K | – | 5974 |
|
|
2018
Q2 | $419K | Buy |
+17,700
| New | +$356K | ﹤0.01% | 3783 |
|
|
2018
Q1 | – | Sell |
-85,500
| Closed | -$1.38M | – | 5682 |
|
|
2017
Q4 | $1.38M | Buy |
85,500
+58,800
| +220% | +$694K | ﹤0.01% | 1962 |
|
|
2017
Q3 | $373K | Buy |
+26,700
| New | +$266K | ﹤0.01% | 3445 |
|
|
2016
Q3 | – | Sell |
-15,200
| Closed | -$35K | – | 4735 |
|
|
2016
Q2 | $35K | Buy |
+15,200
| New | +$50.8K | ﹤0.01% | 3973 |
|
|
2016
Q1 | – | Sell |
-13,900
| Closed | -$43K | – | 4838 |
|
|
2015
Q4 | $43K | Buy |
+13,900
| New | +$38.8K | ﹤0.01% | 3884 |
|
Jane Street's IMMU Position: Q4 2020 in Review
Jane Street sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 144,311 shares — an estimated $12.3M sold.
Jane Street first reported a position in IMMU in Q2 2013 and held it in 17 quarters. The position peaked at $15.9M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Jane Street reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Jane Street sold 144,311 Immunomedics Inc shares in Q4 2020, an estimated $12.3M.
- Jane Street first reported a position in Immunomedics Inc in Q2 2013 and held it in 17 quarters.
- Jane Street's Immunomedics Inc position peaked at $15.9M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.